Your browser doesn't support javascript.
loading
Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression.
Zhang, Xinbo; Rotllan, Noemi; Canfrán-Duque, Alberto; Sun, Jonathan; Toczek, Jakub; Moshnikova, Anna; Malik, Shipra; Price, Nathan L; Araldi, Elisa; Zhong, Wen; Sadeghi, Mehran M; Andreev, Oleg A; Bahal, Raman; Reshetnyak, Yana K; Suárez, Yajaira; Fernández-Hernando, Carlos.
Afiliação
  • Zhang X; Vascular Biology and Therapeutics Program (X.Z., N.R., A.C.-D., J.S., J.T., N.L.P., E.A., W.Z., M.M.S., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Rotllan N; Integrative Cell Signaling and Neurobiology of Metabolism Program, Department of Comparative Medicine (X.Z., N.R., A.C.-D., J.S., N.L.P., E.A., W.Z., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Canfrán-Duque A; Department of Pathology (X.Z., N.R., A.C.-D., J.S., N.L.P., E.A., W.Z., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Sun J; Vascular Biology and Therapeutics Program (X.Z., N.R., A.C.-D., J.S., J.T., N.L.P., E.A., W.Z., M.M.S., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Toczek J; Integrative Cell Signaling and Neurobiology of Metabolism Program, Department of Comparative Medicine (X.Z., N.R., A.C.-D., J.S., N.L.P., E.A., W.Z., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Moshnikova A; Department of Pathology (X.Z., N.R., A.C.-D., J.S., N.L.P., E.A., W.Z., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Malik S; Vascular Biology and Therapeutics Program (X.Z., N.R., A.C.-D., J.S., J.T., N.L.P., E.A., W.Z., M.M.S., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Price NL; Integrative Cell Signaling and Neurobiology of Metabolism Program, Department of Comparative Medicine (X.Z., N.R., A.C.-D., J.S., N.L.P., E.A., W.Z., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Araldi E; Department of Pathology (X.Z., N.R., A.C.-D., J.S., N.L.P., E.A., W.Z., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Zhong W; Vascular Biology and Therapeutics Program (X.Z., N.R., A.C.-D., J.S., J.T., N.L.P., E.A., W.Z., M.M.S., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Sadeghi MM; Integrative Cell Signaling and Neurobiology of Metabolism Program, Department of Comparative Medicine (X.Z., N.R., A.C.-D., J.S., N.L.P., E.A., W.Z., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Andreev OA; Department of Pathology (X.Z., N.R., A.C.-D., J.S., N.L.P., E.A., W.Z., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Bahal R; Vascular Biology and Therapeutics Program (X.Z., N.R., A.C.-D., J.S., J.T., N.L.P., E.A., W.Z., M.M.S., Y.S., C.F.-H.), Yale University School of Medicine, New Haven, CT.
  • Reshetnyak YK; Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine and Yale Cardiovascular Research Center (J.T., M.M.S.), Yale University School of Medicine, New Haven, CT.
  • Suárez Y; Section of Cardiology, Veterans Affairs Connecticut Healthcare System, West Haven (J.T., M.M.S.).
  • Fernández-Hernando C; Department of Physics, University of Rhode Island, Kingston (A.M., O.A.A., Y.K.R.).
Circ Res ; 131(1): 77-90, 2022 06 24.
Article em En | MEDLINE | ID: mdl-35534923

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Aterosclerose / Placa Aterosclerótica Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Aterosclerose / Placa Aterosclerótica Idioma: En Ano de publicação: 2022 Tipo de documento: Article